The Precise Engineering of Expression Vectors Using High-Throughput In-Fusion™ PCR Cloning

Author(s):  
Nick S. Berrow ◽  
David Alderton ◽  
Raymond J. Owens
2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Yanyang Tang ◽  
Justin Saul ◽  
Nirupa Nagaratnam ◽  
Jose M. Martin-Garcia ◽  
Petra Fromme ◽  
...  

2005 ◽  
Vol 33 (6) ◽  
pp. 1407-1408 ◽  
Author(s):  
Y.-H. Hu ◽  
D. Vanhecke ◽  
H. Lehrach ◽  
M. Janitz

Accomplishment of the human and mouse genome projects resulted in accumulation of extensive gene sequence information. However, the information about the biological functions of the identified genes remains a bottleneck of the post-genomic era. Hence, assays providing simple functional information, such as localization of the protein within the cell, can be very helpful in the elucidation of its function. Transfected cell arrays offer a robust platform for protein localization studies. Open reading frames of unknown genes can be linked to a His6-tag or GFP (green fluorescent protein) reporter in expression vectors and subsequently transfected using the cell array. Cellular localization of the transfected proteins is detected either by specific anti-His-tag antibodies or directly by fluorescence of the GFP fusion protein and by counterstaining with organelle-specific dyes. The high throughput of the method in terms of information provided for every single experiment makes this approach superior to classical immunohistological methods for protein localization.


2021 ◽  
Author(s):  
Adam R Bentham ◽  
Mark Youles ◽  
Melanie N Mendel ◽  
Freya A Varden ◽  
Juan Carlos De la Concepcion ◽  
...  

The ability to recombinantly produce target proteins is essential to many biochemical, structural, and biophysical assays that allow for interrogation of molecular mechanisms behind protein function. Purification and solubility tags are routinely used to maximise the yield and ease of protein expression and purification from E. coli. A major hurdle in high-throughput protein expression trials is the cloning required to produce multiple constructs with different solubility tags. Here we report a modification of the well-established pOPIN expression vector suite to be compatible with modular cloning via Type IIS restriction enzymes. This allows users to rapidly generate multiple constructs with any desired tag, introducing modularity in the system and delivering compatibility with other modular cloning vector systems, for example streamlining the process of moving between expression hosts. We demonstrate these constructs maintain the expression capability of the original pOPIN vector suite and can also be used to efficiently express and purify protein complexes, making these vectors an excellent resource for high-throughput protein expression trials.


2009 ◽  
Vol 47 (6) ◽  
pp. 789-795 ◽  
Author(s):  
Jiwon Ahn ◽  
Chung-Hae Choi ◽  
Chang-Mo Kang ◽  
Chun-Ho Kim ◽  
Hee-Moon Park ◽  
...  

2020 ◽  
Vol 22 (Supplement_2) ◽  
pp. ii113-ii113
Author(s):  
Katharina Lindner ◽  
Chin Leng Tan ◽  
Matthias Bozza ◽  
Khwab Sanghvi ◽  
Isabel Poschke ◽  
...  

Abstract Gliomas are tumors with low mutational burden with the majority of them being resistant to checkpoint inhibition due to few immunogenic antigens. Multicenter vaccine trials targeting personalized neoantigens in gliomas demonstrated feasibility and illustrated the challenges of retrieving neoepitope-specific T cells based on the prediction of immunogenic neoepitopes. Here we took an entirely different T cell-centric approach and established a single cell sequencing-based high-throughput T cell receptor (TCR) retrieval platform, exploiting the therapeutic potential of spontaneous intratumoral T cell clonotypes for the development of adoptive cell therapy. We conducted direct ex vivo TCR single cell sequencing from freshly sorted human glioma-infiltrating T cell samples. High fidelity PCR was established to clone TCRs from single cell libraries directly into episomal expression vectors further optimized for T cell therapy. In parallel to standard therapy, patient-derived xenografts were developed and characterized. Tumor-reactivity of retrieved TCRs was demonstrated against patient-derived cell lines. Collectively, we provide a novel sequencing-based platform for high-throughput identification and validation of endogenous glioma-targeting TCRs and demonstrate their therapeutic applicability.


2004 ◽  
Vol 45 (6) ◽  
pp. 383-389 ◽  
Author(s):  
Johannes Warmbold ◽  
Sven Konzack ◽  
Patricia Rischitor ◽  
Daniel Veith ◽  
Kay Vienken ◽  
...  

2007 ◽  
Vol 177 (4S) ◽  
pp. 52-53
Author(s):  
Stefano Ongarello ◽  
Eberhard Steiner ◽  
Regina Achleitner ◽  
Isabel Feuerstein ◽  
Birgit Stenzel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document